BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 21742217)

  • 1. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
    Puri N; Dellinger RP
    Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome?
    Siobal MS; Hess DR
    Respir Care; 2010 Feb; 55(2):144-57; discussion 157-61. PubMed ID: 20105341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute respiratory distress syndrome. Inhaled nitric oxide.
    Hanania NA; Pope C; Guntupalli KK
    Respir Care Clin N Am; 1998 Dec; 4(4):695-709. PubMed ID: 9881400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective pulmonary vasodilation in acute respiratory distress syndrome.
    Kaisers U; Busch T; Deja M; Donaubauer B; Falke KJ
    Crit Care Med; 2003 Apr; 31(4 Suppl):S337-42. PubMed ID: 12682462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence-based approach to acute respiratory distress syndrome.
    Meade MO; Herridge MS
    Respir Care; 2001 Dec; 46(12):1368-76; discussion 1376-9. PubMed ID: 11728297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled epoprostenol to support the severely hypoxemic patient with acute respiratory distress syndrome.
    Arumpanayil A
    Dimens Crit Care Nurs; 2013; 32(5):229-36. PubMed ID: 23933641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled nitric oxide: should it be used in acute respiratory distress syndrome?
    Dellinger RP
    Crit Care Med; 2006 Dec; 34(12):3035-6. PubMed ID: 17130694
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
    Van Heerden PV; Blythe D; Webb SA
    Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide in adults with the acute respiratory distress syndrome.
    Markewitz BA; Michael JR
    Respir Med; 2000 Nov; 94(11):1023-8. PubMed ID: 11127486
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
    Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
    J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications, modifications and technique of ECMO with or without NO-therapy.
    Pappert D; Falke KJ
    Acta Anaesthesiol Scand Suppl; 1996; 109():117-20. PubMed ID: 8901974
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
    Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
    Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of inhaled nitric oxide to children with acute respiratory distress syndrome and its effects on oxygenation and ventilator settings: prospective preliminary report of ten patients.
    Fioretto JR; Bonatto RC; Ricchetti SM; Carpi MF; de Moraes MA; Padovani CR
    Croat Med J; 2001 Oct; 42(5):527-34. PubMed ID: 11596168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide for the adult respiratory distress syndrome.
    Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
    N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhaled nitric oxide: one modality in the treatment of ARDS].
    Carrillo-Esper R; Ramírez-Hernández JM; Gargallo-Hernández JJ; Hernández-Vásquez R; Domínguez-Rodríguez MI; Alemán-Alarcón CE; Gallegos-Rodríguez G
    Gac Med Mex; 1999; 135(4):417-21. PubMed ID: 10491897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide for acute lung injury: no place for NO?
    Adhikari N; Granton JT
    JAMA; 2004 Apr; 291(13):1629-31. PubMed ID: 15069052
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.
    Kinugasa H; Horigome H; Sugiura M; Saito T; Iijima T; Matsui A
    Pediatr Int; 2002 Oct; 44(5):525-7. PubMed ID: 12225554
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
    Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
    Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.